Blueprint Medicines (NASDAQ:BPMC) Now Covered by Analysts at Wolfe Research
Wolfe Research initiated coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com cut shares of Blueprint Medicines from a […]
Wolfe Research initiated coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports. The brokerage issued an outperform rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com cut shares of Blueprint Medicines from a […]
